Physician profile
Arnold Ramirez
NPI 1740243567
$2,926.28
in general payments reported to CMS, 2019-2025
22 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $281 · 2021: $1,473 · 2022: $484 · 2023: $235 · 2024: $48.48 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,226.00 | 2021 | |
| Horizon Therapeutics Plc | $497.81 | 2019-2022 | |
| Avanos Medical | $187.33 | 2021-2023 | Standard Rf Disposables, Coolief* Cooled Radiofrequency |
| Medtronic, INC. | $165.62 | 2025 | Kyphon Express II Kyphopak Tray |
| Bioventus LLC | $119.59 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane, L360 Thigh System |
| Ferring Pharmaceuticals INC. | $111.25 | 2021-2022 | |
| Smith+Nephew, INC. | $95.96 | 2019-2023 | Renasys Go V2 Home, Pico 14 |
| Zimmer Biomet Holdings, INC. | $85.66 | 2019-2020 | |
| Vericel Corporation | $51.65 | 2020-2021 | |
| Genentech USA, INC. | $42.82 | 2021-2022 | |
| Novo Nordisk INC | $42.52 | 2022-2023 | Wegovy |
| Fidia Pharma USA INC. | $40.09 | 2020-2025 | Hymovis |
| Depuy Synthes Sales INC. | $39.52 | 2020 | |
| Orthofix Medical, INC. | $35.08 | 2021-2022 | |
| Electronic Waveform Lab, INC. | $34.64 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragen, INC. | $31.50 | 2020-2021 | |
| Heraeus Medical, LLC. | $29.42 | 2024-2025 | |
| Pacira Therapeutics, INC. | $27.38 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.37 | 2019 | |
| Kci USA, INC. | $18.78 | 2022 | |
| Mvp Orthopedics INC | $14.29 | 2022 | |
| Penumbra, INC. | $10.00 | 2023 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.